Induction of hepatic cytochrome P450s responsible for the metabolism of xenobiotics by nicardipine and other calcium channel antagonists in the male rat

References

• BERTZ, R. J. and GRANNEMAN, G. R., 1997, Use of in vitro and in vivo data to estimate the likelihood of metabolic pharmacokinetic interactions. Clinical Pharmacokinetics, 32, 210–258.
   PubMed Web of Science ®Google Scholar
• BURKE, M. D., THOMPSON, S., WEAVER, R. J., WOLF, C. R. and MAYER, R. T., 1994, Cytochrome P450 specificities of alkoxyresorufin O.dealkylation in human liver microsomes. Biochemical Pharmacology, 48, 923–936.
   PubMed Web of Science ®Google Scholar
• BOURRIE, M., MEUNIER, V., BERGER, Y. and FABRE, G., 1996, Cytochrome P450 isoform inhibitors as a tool for the investigation of metabolic reactions catalyzed by human liver microsomes. Journal of Pharmacology and Experimental Therapuetics, 227, 321–332.
   Google Scholar
• CHOMCZYNSKI, P. and SACCHI, N., 1987, Single-step method of RNA isolation by acid guanidinium thiocyanate—phenol—chloroform extraction. Analytical Biochemistry, 162, 156–159.
   PubMed Web of Science ®Google Scholar
• DEGAWA, M., TANIMURA, S., AGATSUMA, T. and HASHIMOTO, Y., 1989, Hepatocarcinogenic heterocyclic aromatic amines that induce cytochrome P-448 isozymes, mainly cytochrome P-448H (P-450 1A2), responsible for mutagenic activation of the carcinogens in rat liver. Car cinogenesis, 10, 1119–1122.
   PubMedGoogle Scholar
• DROCOURT, L., PASCUSSI, J.-M., ASSENAT, E., FABRE, J.-M., MAUREL, P. and VILAREM, M.-J., 2001, Calcium channel modulators of the dihydropyridine family are human pregnane X receptor activators and inducers of CYP3A, CYP2B, and CYP2C in human hepatocytes. Drug Metabolism and Disposition, 29, 1325–1331.
   Google Scholar
• GALISTEO, M., MARC, M., FAUTREL, A., GUILLOUZO, A., CORCOS, L. and LAGADIC-GOSSMANN, D., 1999, Involvement of cyclic nucleotide- and calcium-regulated pathways in phenobarbital-induced cytochrome P-450 3A expression in mouse primary hepatocytes. Journal of Pharmacology and Experimental Therapeutics, 290, 1270–1277.
   Google Scholar
• GOMEZ-LECHON, M. J., JovER, R., DONATO, T., PONSODA, X., RODRIGUEZ, C., STENZEL, K. G., KLOCKE, R., PAUL, D., GUILLEN, I., BORT, R. and CASTELL, J. V., 1998, Long-term expression of differentiated functions in hepatocytes cultured in three-dimensional collagen matrix. Journal of Cellular Physiology, 177, 553–562.
   Google Scholar
• GUENGERICH, F. P., BRIAN, W. R., IWASAKI, M., SARI, M.-A., BAARNHIELM, C. and BERNTSSON, P., 1991, Oxidation of dihydropyridine calcium channel blockers and analogues by human liver cytochrome P-450 3A4. Journal of Medicinal Chemistry, 34, 1838–1833.
   Google Scholar
• GUENGERICH, F. P., MARTIN, M. V., BEAUNE, P. H., KREMERS, P., WOLFF, T. and WAXMAN, D. J., 1986, Characterization of rat and human liver microsomal cytochrome P-450 forms involved in nifedipine oxidation, a prototype for genetic polymorphism in oxidative drug metabolism. Journal of Biological Chemistry, 261, 5051–5060.
   PubMed Web of Science ®Google Scholar
• HUGHES, B. P., MILTON, S. E., BARRITT, G. J. and AULD, A. M., 1986, Studies with varapamil and nifedipine provide evidence for the presence in the liver cell plasma membrane of two types of Ca2+ inflow transporter which are dissimilar to potential-operated Ca2+ channels. Biochemical Pharmacology, 35, 3045–3052.
   PubMed Web of Science ®Google Scholar
• JOANNARD, F., GALISTEO, M., CORCOS, L., GuiLLouzo, A. and LAGADIC-GOSSMANN, D., 2000, Regulation of phenobarbital-induction of CYP2B and CYP3A genes in rat cultured hepatocytes: involvement of several serine/threonine protein kinases and phosphatases. Cell Biology and Toxicology, 16, 325–337.
   Google Scholar
• KFIS, S. G., REDDY, S. L., STATES, J. C. and NOVAK, R. F., 1991, Pyridine effects on expression and molecular regulation of the cytochrome P450 1A gene subfamily. Molecular Pharmacology, 40, 52–57.
   PubMedGoogle Scholar
• KOLEVA, M. R. and STOYCHEV, T. S., 1993, On the enzyme-inducing action of calcium antagonists. Archives of Toxicology, 67, 294–296.
   PubMedGoogle Scholar
• KOLEVA, M. R. and STOYCHEV, T. S., 1995, Effect of nifedipine, veramapil and diltiazem on the enzyme-inducing activity of phenobarbital and beta-naphthoflavone. General Pharmacology, 26, 225–228.
   PubMedGoogle Scholar
• KROEMER, H. K., GAUTIER, J. C., BEAUNE, P., HENDERSON, C., WOLF, C. R. and EICHELBAU M., 1993, Identification of P450 enzymes involved in metabolism of veramapil in humans. Archives of Pharmacology, 348, 332–337.
   PubMed Web of Science ®Google Scholar
• LOWRY, O. H., ROSENBROUGH, N. J., FARR, A. L. and RANDALL, R. J., 1951, Protein measurement with the folin phenol reagent. Journal of Biological Chemistry, 193, 265–275.
   PubMed Web of Science ®Google Scholar
• MAENpAA, J., RUSKOAHO, H. and PELKONEN, O., 1989, Inhibition of hepatic microsomal drug metabolism in rats by five calcium antagonists. Pharmacology and Toxicology, 64, 446–450.
   PubMedGoogle Scholar
• MARC, N., GALISTEO, M., LAGADIC-GOSSMANN, D., FAUTREL, A., JOANNARD, F., GUILLOUZO, A. and CORCOS, L., 2000, Regulation of phenobarbital induction of the cytochrome P450 2b9/10 genes in primary mouse hepatocyte culture. European Journal of Biochemistry, 267, 936–970.
   Google Scholar
• MURRAY, M. and BUTLER, A. M., 1996, Enhanced inhibition of microsomal cytochrome P450 3A2 in rat liver during diltiazem biotransformation. Journal of Pharmacology and Experimental Therapeutics, 279, 1447–1452.
   PubMedGoogle Scholar
• NEMOTO, K., MIYATA, S., NEMOTO, F., YASUMOTO, T., MURAI, U., KAGEYAMA, H. and DEGAWA, M., 2000, Gene expression of neurotrophins and their receptors in lead nitrate-induced rat liver hyperplasia. Biochemical Biophysical Research Communications, 275, 472–476.
   PubMed Web of Science ®Google Scholar
• OINONEN, T. and LINDROS, K. O., 1995, Hormonal regulation of the zonated expression of cytochrome P-450 3A in rat liver. Biochemical Journal, 309, 55–61.
   PubMedGoogle Scholar
• OMIECINSKI, C. J., HASSETT, C. and COSTA, P., 1990, Developmental expression and in situ localization of the phenobarbital-inducible rat hepatic mRNAs for cytochromes CYP2B1, CYP2B2, CYP2C6, and CYP3A1. Molecular Pharmacology, 38, 462–470.
   PubMed Web of Science ®Google Scholar
• PICHARD, L., GILLET, G., FABRE, I., DALET-BELUCHE, I., BONFILS, C., THENOT, J.-P. and MAUREL, P., 1990, Identification of the rabbit and human cytochromes P-450 3A as the major enzymes involved in the N-demethylation of diltiazem. Drug Metabolism Disposition, 18, 711–719.
   Google Scholar
• STRIGGOW, F. and BOHNENSACK, R., 1993, Verapamil and diltiazem inhibit receptor-operated calcium channels and intracellular calcium oscillations in rat hepatocytes. FEBS Letters, 318, 341–344.
   PubMed Web of Science ®Google Scholar
• WHITLOCK, J. P., Jr., 1999, Induction of cytochrome P450 1A1. Annual Reviews in Pharmacology Toxicology, 39, 103–125.
   Google Scholar
• ZANGAR, R. C., OKITA, J. R., KIM, H., THOMAS, P. E., ANDERSON, A., EDWARDS, R. J., SPRINGER, D. L. and OKITA, R. T., 1999, Effect of calcium channel antagonists nifedipine and nicardipine on rat cytochrome P-450 2B and 3A forms. Journal of Pharmacology and Experimental Therapeutics, 290, 1436–1441.
   PubMedGoogle Scholar